Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MBOAT4 | Q96T53 | 3/20 | 0.36 |
| ▸ | PDE2A | O00408 | 5/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3276173 | 0.85 | ALDH1A1 (0.39) | ALDH1A1KMT2APOLBTSHRMBOAT4 | |
| SCHEMBL23925483 | 0.82 | ALDH1A1 (0.38) | ALDH1A1KMT2APOLBTSHRMBOAT4 | |
| SCHEMBL23944468 | 0.82 | KDM4E (0.43) | ALDH1A1KMT2APOLBTSHRKDM4E | |
| SCHEMBL5622818 | 0.79 | ALDH1A1 (0.39) | ALDH1A1KMT2APOLBTSHRMBOAT4 | |
| SCHEMBL6189796 | 0.79 | SMN1; SMN2 (0.41) | ALDH1A1KMT2APOLBTSHRMBOAT4 | |
| SCHEMBL23925484 | 0.79 | EGLN2 (0.48) | ALDH1A1KMT2APOLBTSHR | |
| SCHEMBL6068158 | 0.79 | ALDH1A1 (0.36) | ALDH1A1KMT2APOLBTSHRMBOAT4 | |
| SCHEMBL6068039 | 0.78 | MBOAT4 (0.34) | ALDH1A1KMT2APOLBTSHRMBOAT4 | |
| SCHEMBL6068255 | 0.76 | ALDH1A1 (0.32) | ALDH1A1KMT2APOLBTSHRPDE2A | |
| SCHEMBL7495293 | 0.75 | ALDH1A1 (0.41) | ALDH1A1KMT2APOLBTSHRMBOAT4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7148227-B2 | Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances | BASF AKTIENGESELLSCHAFT (DE) | 2006-12-12 | — | — | US | disclosed |
| US-20050176736-A1 | Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances | BASF AKTIENGESELLSCHAFT (DE) | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176736-A1 | Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances | CBR1, CBR3, HAO1 | ALDH1A1 89/4885KMT2A 3349/4885POLB 2410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.